ApprovalTrail

Drug · DIN 02415380

MYA

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since September 1, 2020; first marketed May 20, 2014.
Drug Identification Number (DIN)
02415380
Company (DIN owner)
Apotex Inc.Toronto, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Drospirenone and estrogen G03AA12
Class
Human
Record last updated
June 16, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DROSPIRENONE3.00 MG
ETHINYL ESTRADIOL0.02 MG

Notices of Compliance

Health Canada approvals that name this DIN.